Compare · ALXN vs REXN
ALXN vs REXN
Side-by-side comparison of Alexion Pharmaceuticals, Inc. (ALXN) and Rexahn Pharmaceuticals, Inc. (REXN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALXN and REXN operate in Major Pharmaceuticals (Health Care), so they compete in similar markets.
- Company
- Alexion Pharmaceuticals, Inc.
- Rexahn Pharmaceuticals, Inc.
- Price
- -
- -
- Market cap
- -
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Pharmaceuticals
- Major Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1996
- n/a
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
Latest ALXN
- Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer
- SEC Form 15-12G filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
Latest REXN
- MaxCyte Appoints Douglas Swirsky As Chief Financial Officer
- MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
- Rexahn Pharmaceuticals Announces Expected Effectiveness of Reverse Stock Split and Merger Transaction with Ocuphire Pharma
- Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma
- SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, REXN, and WPX Shareholders About Its Ongoing Investigations